Blog

Scientific progress was the overall objective pursued by the HipGen study funded by Tobias Winkler under EU Horizon 2020 (Grant 779293): Its aim was to bring the first regenerative therapy for improved recovery after muscle injury to market approval - time for a recapitulation!

Progress comes from innovation. But innovation requires the right environment – creative (and hard-working) people; room for experiments and failure; and not least the expectation that success can lead to rewards in the end. The larger the investment is – in terms of money, time or manpower – the more important this chance for reward becomes.

The 1st ATiO Conference, hosted at the Hotel de Rome in Berlin, has come to an end and set the beginning of a fruitful joint endeavour to accelerate the progress in the field of advanced therapies in orthopaedics - from bench to bedside.

Here you find all pictures and impressions taken throughout the course of the ATiO Conference 2022.

The field of advanced therapies is more exciting and promising than ever – we see more and more advancement in research concerning oncology, cardiology - and orthopaedics to name a few. Years ago, we identified the need of a dedicated group and conference for advanced therapies with musculoskeletal indications.